iAdvantage Software, a provider of electronic study management tools, announces the addition of Richard Hellmer as director of business development and Bob Winters as senior account executive
"Richard Hellmer and Bob Winters bring additional life science knowledge to the iAdvantage business development strategy.
"Their seasoned expertise will not only support the recent launch of eStudy 5.0 as an installed or hosted solution and ePublisher as a stand alone product, but will add value to the clients they serve," remarked Fate Thompson, president and CEO of iAdvantage Software.
Richar Hellmer, director of business development.
"I am excited to be joining iAdvantage during this time of great opportunity," said Richard Hellmer.
"iAdvantage has an unrivaled position, offering flexible leading-edge electronic study management solutions that are all 100% web-based.
"I look forward to working with iAdvantage and am eager to significantly expand the iAdvantage customer base and strengthen existing relationships".
As the director of business development, Richard Hellmer brings more than eight years of experience in the high-technology field of the life sciences.
During his work history, Hellmer has successfully created and communicated business and marketing strategies for a number of software and technology companies, helping to increase market share and revenue within highly competitive environments.
Most recently, Hellmer served as regional director for Nervana, a high-technology software startup.
He received his BS in biochemistry from Virginia Tech.
Bob Winters, senior account executive.
"I have seen and experienced first hand the challenges facing CROs today: disparate data, data integrity and compliance issues along with reporting headache".
"I am looking forward to bringing CROs solutions that will not only relieve their stress but will have a positive impact on their bottom-line," commented Bob Winters.
Bob Winters has joined iAdvantage as a senior account executive.
His career spans over 25 years in the life sciences arena, most recently as senior director of business development for BASi, a contract research organisation focused on the in-life portions of pharmaceutical development.